1. Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1β
   Dequina A. Nicholas et al, 2017, PLOS ONE CrossRef
2. Cancer Stem Cell Markers for Urinary Carcinoma
   Pu Xia et al, 2022, Stem Cells International CrossRef
3. Drug repurposing: A novel strategy to target cancer stem cells and therapeutic resistance
   Divya Ajmeera et al, 2024, Genes & Diseases CrossRef
4. CD133 and CD44 as cancer stem cell markers in bladder carcinoma
   Rania ES. Wasfy et al, 2017, Egyptian Journal of Pathology CrossRef
5. Membrane-associated RING-CH 7 inhibits stem-like capacities of bladder cancer cells by interacting with nucleotide-binding oligomerization domain containing 1
   Junlong Zhuang et al, 2024, Cell & Bioscience CrossRef
6. Tissue-specific cancer stem/progenitor cells: Therapeutic implications
   Amani Yehya et al, 2023, World Journal of Stem Cells CrossRef
7. Cancer stem cells: an insight into the development of metastatic tumors and therapy resistance
   Tahsin Nairuz et al, 2023, Stem Cell Reviews and Reports CrossRef
8. Planarians as models of cadmium-induced neoplasia provide measurable benchmarks for mechanistic studies
   Evelyn B. Voura et al, 2017, Ecotoxicology and Environmental Safety CrossRef
9. Unraveling the journey of cancer stem cells from origin to metastasis
   Rama Krishna Nimmakayala et al, 2019, Biochimica et Biophysica Acta (BBA) - Reviews on Cancer CrossRef
10. Aptamers as Smart Ligands for Targeted Drug Delivery in Cancer Therapy
    Zongyi Wei et al, 2022, Pharmaceutics CrossRef
11. Cancer stem cells and epithelial–mesenchymal transition in urothelial carcinoma: Possible pathways and potential therapeutic approaches
    Dong Fang et al, 2018, International Journal of Urology CrossRef
12. Expression of cancer stem cells markers in urinary bladder urothelial carcinoma and its precursor lesions
    Jaromir Hacek et al, 2021, Biomedical Papers CrossRef
13. The number of cancer stem cells in the tumor tissue and perifocal tissue of non-muscle invasive bladder cancer
    L. I. Belyakova et al, 2022, South Russian Journal of Cancer CrossRef
14. A novel in situ permeation system and its utility in cancer tissue ablation
    MASAMI WATANABE, 2015, International Journal of Oncology CrossRef
15. Novel Therapeutics Targeting Cancer Stem Cell Surface Markers
    Sujani Kodagoda Gamage et al, 2023, Cancer Stem Cells: Basic Concept and Therapeutic Implications CrossRef
16. Curcumin inhibits bladder cancer stem cells by suppressing Sonic Hedgehog pathway
    Dengdian Wang et al, 2017, Biochemical and Biophysical Research Communications CrossRef
17. Delivery of Therapeutics Using Nanocarriers for Targeting Cancer Cells and Cancer Stem Cells
    Sangeetha Krishnamurthy et al, 2015, Nanomedicine CrossRef
18. Targeted Delivery of Therapeutics to Urological Cancer Stem Cells
    Qiang Liu et al, 2020, Current Pharmaceutical Design CrossRef
19. Bladder Cancer Stem-Like Cells: Their Origin and Therapeutic Perspectives
    Tomokazu Ohishi et al, 2015, International Journal of Molecular Sciences CrossRef
20. Impact of SOX2 function and regulation on therapy resistance in bladder cancer
    Guodong Chen et al, 2022, Frontiers in Oncology CrossRef
21. SIU–ICUD consultation on bladder cancer: basic science
    David J. McConkey et al, 2019, World Journal of Urology CrossRef
22. Expression of Cancer Stem Cell Markers OCT4 and CD133 in Transitional Cell Carcinomas
    Shirin Sedaghat et al, 2017, Applied Immunohistochemistry & Molecular Morphology CrossRef